RTI-171

Nowadays, RTI-171 is a topic that has captured the attention of people all over the world. Whether due to its impact on society, its historical relevance or its influence on everyday life, RTI-171 has generated growing interest in different sectors. In this article, we will explore in depth the most relevant aspects of RTI-171, from its origin to its evolution today. We will analyze its implications, its challenges and the possible solutions that have been proposed to address this issue. Additionally, we will examine expert opinions and the experiences of individuals who have been affected by RTI-171. Get ready to immerse yourself in a complete and enriching analysis of RTI-171!

RTI-171
Identifiers
  • 3-methyl-5-octan-4-yl]-1,2-oxazole
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC19H24N2O
Molar mass296.414 g·mol−1
3D model (JSmol)
  • n1oc(cc1C)34N(C)(C3c2ccc(cc2)C)CC4
  • InChI=1S/C19H24N2O/c1-12-4-6-14(7-5-12)16-11-15-8-9-17(21(15)3)19(16)18-10-13(2)20-22-18/h4-7,10,15-17,19H,8-9,11H2,1-3H3/t15-,16+,17+,19-/m0/s1 ☒N
  • Key:JWOFBAPJYPWTNI-FAJBIJEISA-N ☒N
 ☒NcheckY (what is this?)  (verify)

(–)-2β-(3-Methylisoxazol-5-yl)-3β-(p-tolyl)tropane (RTI-4229-171) is a phenyltropane derivative which acts as a selective dopamine reuptake inhibitor, with a relatively slow onset of action and short duration of effects found in animal studies.[1] However, other studies have shown it to have the most pronounced effects in terms of speed of onset and rate of stimulation among many differing phenyltropanes.[2]

See also

References

  1. ^ Kimmel HL, Carroll FI, Kuhar MJ (December 2001). "Locomotor stimulant effects of novel phenyltropanes in the mouse". Drug and Alcohol Dependence. 65 (1): 25–36. doi:10.1016/S0376-8716(01)00144-2. PMID 11714587.
  2. ^ Kimmel HL, O'Connor JA, Carroll FI, Howell LL (January 2007). "Faster onset and dopamine transporter selectivity predict stimulant and reinforcing effects of cocaine analogs in squirrel monkeys". Pharmacology, Biochemistry, and Behavior. 86 (1): 45–54. doi:10.1016/j.pbb.2006.12.006. PMC 1850383. PMID 17258302.